Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Maurizio Rocchetti

Showing results (11-20 of 27) with videos related to

Pageof 3
Sort By:
British Journal of Clinical Pharmacology|March 9, 2005
A predictive model for exemestane pharmacokinetics/pharmacodynamics incorporating the effect of food and formulationMarta Valle, Enrico Di Salle, Maria Gabriella Jannuzzo, et al.
Cancer Chemotherapy and Pharmacology|February 23, 2013
Predictive pharmacokinetic-pharmacodynamic modeling of tumor growth after administration of an anti-angiogenic agent, bevacizumab, as single-agent and combination therapy in tumor xenograftsMaurizio Rocchetti, Massimiliano Germani, Francesca Del Bene, et al.
Cancer Chemotherapy and Pharmacology|July 30, 2008
A model-based approach to the in vitro evaluation of anticancer activityFrancesca Del Bene, Massimiliano Germani, Giuseppe De Nicolao, et al.
European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences|May 8, 2007
Evaluation of a basic physiologically based pharmacokinetic model for simulating the first-time-in-animal studyMassimiliano Germani, Patrizia Crivori, Maurizio Rocchetti, et al.
Cancer Research|February 12, 2004
Predictive pharmacokinetic-pharmacodynamic modeling of tumor growth kinetics in xenograft models after administration of anticancer agentsMonica Simeoni, Paolo Magni, Cristiano Cammia, et al.
Pharmaceutics|March 6, 2021
In Vitro-In Vivo Correlation (IVIVC) Population Modeling for the In Silico Bioequivalence of a Long-Acting Release Formulation of ProgesteroneElena M Tosca, Maurizio Rocchetti, Elena Pérez, et al.
CPT: Pharmacometrics & Systems Pharmacology|February 8, 2024
In silico trial for the assessment of givinostat dose adjustment rules based on the management of key hematological parameters in polycythemia vera patientsElena M Tosca, Alessandro De Carlo, Roberta Bartolucci, et al.
Cancer Chemotherapy and Pharmacology|August 9, 2003
Assessment of normal and tumor tissue uptake of MAG-CPT, a polymer-bound prodrug of camptothecin, in patients undergoing elective surgery for colorectal carcinomaNenad Sarapa, Margaret R Britto, William Speed, et al.
Molecular Medicine (Cambridge, Mass.)|April 5, 2013
Preclinical studies in the mdx mouse model of duchenne muscular dystrophy with the histone deacetylase inhibitor givinostatSilvia Consalvi, Chiara Mozzetta, Paolo Bettica, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 11, 2003
Dose escalation study of intravenous estramustine phosphate in combination with Paclitaxel and Carboplatin in patients with advanced prostate cancerWilliam Kevin Kelly, Andrew X Zhu, Howard Scher, et al.
Pageof 3

Showing results (11-20 of 27) with videos related to

Sort By:
Pageof 3
British Journal of Clinical Pharmacology|March 9, 2005
A predictive model for exemestane pharmacokinetics/pharmacodynamics incorporating the effect of food and formulationMarta Valle, Enrico Di Salle, Maria Gabriella Jannuzzo, et al.
Cancer Chemotherapy and Pharmacology|February 23, 2013
Predictive pharmacokinetic-pharmacodynamic modeling of tumor growth after administration of an anti-angiogenic agent, bevacizumab, as single-agent and combination therapy in tumor xenograftsMaurizio Rocchetti, Massimiliano Germani, Francesca Del Bene, et al.
Cancer Chemotherapy and Pharmacology|July 30, 2008
A model-based approach to the in vitro evaluation of anticancer activityFrancesca Del Bene, Massimiliano Germani, Giuseppe De Nicolao, et al.
European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences|May 8, 2007
Evaluation of a basic physiologically based pharmacokinetic model for simulating the first-time-in-animal studyMassimiliano Germani, Patrizia Crivori, Maurizio Rocchetti, et al.
Cancer Research|February 12, 2004
Predictive pharmacokinetic-pharmacodynamic modeling of tumor growth kinetics in xenograft models after administration of anticancer agentsMonica Simeoni, Paolo Magni, Cristiano Cammia, et al.
Pharmaceutics|March 6, 2021
In Vitro-In Vivo Correlation (IVIVC) Population Modeling for the In Silico Bioequivalence of a Long-Acting Release Formulation of ProgesteroneElena M Tosca, Maurizio Rocchetti, Elena Pérez, et al.
CPT: Pharmacometrics & Systems Pharmacology|February 8, 2024
In silico trial for the assessment of givinostat dose adjustment rules based on the management of key hematological parameters in polycythemia vera patientsElena M Tosca, Alessandro De Carlo, Roberta Bartolucci, et al.
Cancer Chemotherapy and Pharmacology|August 9, 2003
Assessment of normal and tumor tissue uptake of MAG-CPT, a polymer-bound prodrug of camptothecin, in patients undergoing elective surgery for colorectal carcinomaNenad Sarapa, Margaret R Britto, William Speed, et al.
Molecular Medicine (Cambridge, Mass.)|April 5, 2013
Preclinical studies in the mdx mouse model of duchenne muscular dystrophy with the histone deacetylase inhibitor givinostatSilvia Consalvi, Chiara Mozzetta, Paolo Bettica, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 11, 2003
Dose escalation study of intravenous estramustine phosphate in combination with Paclitaxel and Carboplatin in patients with advanced prostate cancerWilliam Kevin Kelly, Andrew X Zhu, Howard Scher, et al.
Pageof 3